Tirzepatide BNF NICE
This indicates high public interest in GLP-1 RAs and highlights priorities for clinical and policy communities, including monitoring side effects, addressing access barriers, and acknowledging both the physical and psychological benefits of these drugs
PubMed Central , pmc.ncbi.nlm.nih.gov/articles/PMC10674813/
FMU graduates embody this philosophy every day blending advanced diagnostics, compassionate listening, and precision lifestyle medicine to help patients achieve metabolic freedom
The only legal route to access retatrutide in the UK is participation in a regulated clinical trial
The lead authors of the study are Mahesh Umapathysivam, MBBS, DPhil, an endocrinologist and clinical researcher at Adelaide University in Australia and a former trainee with Gloyn, and Elisa Araldi, PhD, associate professor of medicine and surgery at the University of Parma in Italy and a former trainee with Stoffel